Europlasma Statistics

Total Valuation

Europlasma has a market cap or net worth of GBP 4.39 million. The enterprise value is 14.09 million.

Market Cap	4.39M
Enterprise Value	14.09M

Important Dates

The last earnings date was Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.58B
Shares Outstanding	n/a
Shares Change (YoY)	+1,340.94%
Shares Change (QoQ)	-51.93%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.12
PB Ratio	-0.48
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.11
EV / Sales	0.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.37

Financial Position

The company has a current ratio of 0.77

Current Ratio	0.77
Quick Ratio	0.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.10
Interest Coverage	-8.37

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-30.38%
Return on Invested Capital (ROIC)	-312.97%
Return on Capital Employed (ROCE)	-208.60%
Revenue Per Employee	88,964
Profits Per Employee	-31,772
Employee Count	398
Asset Turnover	0.79
Inventory Turnover	1.57

Taxes

Income Tax	-2.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.59% in the last 52 weeks. The beta is 0.40, so Europlasma's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-98.59%
50-Day Moving Average	0.01
200-Day Moving Average	11,312.65
Relative Strength Index (RSI)	19.93
Average Volume (20 Days)	235,922

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Europlasma had revenue of GBP 35.41 million and -12.65 million in losses. Loss per share was -62.36.

Revenue	35.41M
Gross Profit	18.72M
Operating Income	-21.74M
Pretax Income	-15.43M
Net Income	-12.65M
EBITDA	-11.47M
EBIT	-21.74M
Loss Per Share	-62.36

Full Income Statement

Balance Sheet

The company has 1.45 million in cash and 11.30 million in debt, giving a net cash position of -9.86 million.

Cash & Cash Equivalents	1.45M
Total Debt	11.30M
Net Cash	-9.86M
Net Cash Per Share	n/a
Equity (Book Value)	-9.22M
Book Value Per Share	-0.16
Working Capital	-9.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.00 million and capital expenditures -1.25 million, giving a free cash flow of -10.25 million.

Operating Cash Flow	-9.00M
Capital Expenditures	-1.25M
Free Cash Flow	-10.25M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 52.86%, with operating and profit margins of -61.41% and -35.71%.

Gross Margin	52.86%
Operating Margin	-61.41%
Pretax Margin	-43.59%
Profit Margin	-35.71%
EBITDA Margin	-32.39%
EBIT Margin	-61.41%
FCF Margin	n/a

Dividends & Yields

Europlasma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,340.94%
Shareholder Yield	n/a
Earnings Yield	-287.75%
FCF Yield	-233.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0002.

Last Split Date	May 28, 2024
Split Type	Reverse
Split Ratio	0.0002

Scores

Europlasma has an Altman Z-Score of -6.03 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.03
Piotroski F-Score	4